ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced it will release its third quarter 2021 financial results on November 1, 2021, at 8:30 a.m. ET.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

earnings

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

10/29/2021 - 04:30 PM EDT

BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2021 financial results on Monday, November 1, 2021.

Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:

Date			Monday, November 1, 2021
Time			8:30 a.m. ET
Toll free (U.S.)			877-876-9173
Webcast (live and replay)			www.anipharmaceuticals.com, under the “Investors" section

A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for one-week by dialing 800-938-2243 and entering access code 6513021.

About ANI

ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.